<!doctype html>
<html lang="en"
    ><head>
        <meta charset="UTF-8" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />
        <link rel="icon" type="image/x-icon" href="/assets/favicon.png" />
        <title>Project Description</title>

        <link rel="preconnect" href="https://static.igem.wiki" />

        <link rel="preconnect" href="https://fonts.googleapis.com" />
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin="" />
        <link href="https://fonts.googleapis.com/css2?family=Baloo+2:wght@400..800&amp;display=swap" rel="stylesheet" />
        <!-- <link href="https://fonts.googleapis.com/css2?family=Atkinson+Hyperlegible:ital,wght@0,400;0,700;1,400;1,700&display=swap" rel="stylesheet"> -->
        <!-- <link href="https://fonts.googleapis.com/css2?family=Bellota+Text:ital,wght@0,300;0,400;0,700;1,300;1,400;1,700&display=swap" rel="stylesheet"> -->

        <link rel="stylesheet" type="text/css" href="/styles/globalStylesheet.css" />
        <script type="text/javascript" src="/scripts/globalLibrary.js"></script>
        <link rel="stylesheet" type="text/css" href="/styles/parallax-doodle.css" /><link
            rel="stylesheet"
            type="text/css"
            href="/styles/header.css" /><link rel="stylesheet" type="text/css" href="/styles/body.css" /><link
            rel="stylesheet"
            type="text/css"
            href="/styles/content.css" /><link rel="stylesheet" type="text/css" href="/styles/footer.css" /><link
            rel="stylesheet"
            type="text/css"
            href="/styles/searchbar.css" /><link rel="stylesheet" type="text/css" href="/styles/catalogue.css" /><link
            rel="stylesheet"
            type="text/css"
            href="/styles/title-card.css" /><link rel="stylesheet" type="text/css" href="/styles/outline.css" /><script
            type="text/javascript"
            src="/scripts/responsivenessHandler.js"
            defer=""
        ></script
        ><script type="text/javascript" src="/scripts/parallax-doodle.js" defer=""></script
        ><script type="text/javascript" src="/scripts/content.js" defer=""></script
        ><script type="text/javascript" src="/scripts/footer.js" defer=""></script
        ><script type="text/javascript" src="https://cdn.jsdelivr.net/npm/fuse.js/dist/fuse.min.js" defer=""></script
        ><script type="text/javascript" src="/scripts/searchbar.js" defer=""></script
        ><script type="text/javascript" src="/scripts/catalogue.js" defer=""></script
        ><script type="text/javascript" src="/scripts/title-card.js" defer=""></script
        ><script type="text/javascript" src="/scripts/outline.js" defer=""></script
    ></head>

    <body>
        <painted-template>
            <painted-parallax-doodle>
                <div id="parallax-doodle-container"
                    ><img
                        src="/assets/logos/resisense/ResiSense Orange Logo.svg"
                        style="translate: 54vw 540px; animation-name: parallax-doodle-y6zv3o" /><img
                        src="/assets/doodles/e coli.svg"
                        style="translate: 22vw 4040px; animation-name: parallax-doodle-zpr82w" /><img
                        src="/assets/doodles/red blood cell.svg"
                        style="translate: 59vw 1860px; animation-name: parallax-doodle-mloyk2" /><img
                        src="/assets/doodles/virus.svg"
                        style="translate: 87vw 3260px; animation-name: parallax-doodle-xml3hy" /><img
                        src="/assets/doodles/drug.svg"
                        style="translate: 20vw 4900px; animation-name: parallax-doodle-i5p3ta" /><img
                        src="/assets/doodles/bacteria.svg"
                        style="translate: 71vw 680px; animation-name: parallax-doodle-y3mk8q" /><img
                        src="/assets/doodles/e coli.svg"
                        style="translate: 34vw 1200px; animation-name: parallax-doodle-eyl7ll" /><img
                        src="/assets/doodles/virus.svg"
                        style="translate: 64vw 3380px; animation-name: parallax-doodle-38i1z6" /><img
                        src="/assets/doodles/drug.svg"
                        style="translate: 7vw 1980px; animation-name: parallax-doodle-rgomeq" /><img
                        src="/assets/doodles/virus.svg"
                        style="translate: 3vw 6540px; animation-name: parallax-doodle-mhc8fs" /><img
                        src="/assets/doodles/bacteria.svg"
                        style="translate: 48vw 2760px; animation-name: parallax-doodle-3dfbzi" /><img
                        src="/assets/doodles/dna.svg"
                        style="translate: 61vw 160px; animation-name: parallax-doodle-3u0uvo" /><img
                        src="/assets/doodles/dna.svg"
                        style="translate: 83vw 7220px; animation-name: parallax-doodle-605w1t" /><img
                        src="/assets/doodles/e coli.svg"
                        style="translate: 32vw 6500px; animation-name: parallax-doodle-cun3wc" /><img
                        src="/assets/doodles/bacteria.svg"
                        style="translate: 56vw 6020px; animation-name: parallax-doodle-oowzh5" /><img
                        src="/assets/doodles/red blood cell.svg"
                        style="translate: 79vw 7680px; animation-name: parallax-doodle-jt74q2" /><img
                        src="/assets/doodles/bacteria.svg"
                        style="translate: 31vw 5980px; animation-name: parallax-doodle-u5i91w" /><img
                        src="/assets/logos/resisense/ResiSense Orange Logo.svg"
                        style="translate: 63vw 5660px; animation-name: parallax-doodle-ewv9xo" /><img
                        src="/assets/doodles/syringe.svg"
                        style="translate: 20vw 700px; animation-name: parallax-doodle-w1piei" /><img
                        src="/assets/doodles/virus.svg"
                        style="translate: 25vw 5160px; animation-name: parallax-doodle-glpaok" /><img
                        src="/assets/doodles/syringe.svg"
                        style="translate: 49vw 2080px; animation-name: parallax-doodle-1jx16b" /><img
                        src="/assets/doodles/dna.svg"
                        style="translate: 0vw 4800px; animation-name: parallax-doodle-wwwdvt" /><img
                        src="/assets/doodles/syringe.svg"
                        style="translate: 79vw 5540px; animation-name: parallax-doodle-kkxr8b" /><img
                        src="/assets/doodles/syringe.svg"
                        style="translate: 80vw 1160px; animation-name: parallax-doodle-v41qb8" /><img
                        src="/assets/doodles/drug.svg"
                        style="translate: 5vw 7660px; animation-name: parallax-doodle-klhi9n" /><img
                        src="/assets/doodles/red blood cell.svg"
                        style="translate: 5vw 3140px; animation-name: parallax-doodle-x6avq8" /><img
                        src="/assets/doodles/dna.svg"
                        style="translate: 99vw 3780px; animation-name: parallax-doodle-6liq4y" /><img
                        src="/assets/logos/resisense/ResiSense Orange Logo.svg"
                        style="translate: 23vw 20px; animation-name: parallax-doodle-7bx8bh" /><img
                        src="/assets/doodles/e coli.svg"
                        style="translate: 77vw 6240px; animation-name: parallax-doodle-icf5pk" /><img
                        src="/assets/doodles/red blood cell.svg"
                        style="translate: 73vw 4800px; animation-name: parallax-doodle-7g3dch"
                /></div>
            </painted-parallax-doodle>
            <painted-header>
                <header>
                    <div class="logo-container">
                        <a href="/" class="logo"> </a>
                    </div>
                    <div class="header-shelf">
                        <div class="header-items-container">
                            <div class="header-leftside">
                                <div class="logo-name-text">
                                    <a href="/"> ResiSense </a>
                                </div>
                                <div class="logo-flavour-text"> Finding resistant pathogens one species at a time </div>
                            </div>
                            <div class="header-rightside">
                                <painted-searchbar>
                                    <search class="searchbar">
                                        <input
                                            type="search"
                                            class="searchfield"
                                            id="searchfield"
                                            placeholder="Search for a page..."
                                        />
                                        <button type="submit" class="search-button" id="search-button">üîç</button>
                                    </search>
                                </painted-searchbar>
                                <painted-hamburger-menu> üçî </painted-hamburger-menu>
                            </div>
                            <div class="page-title hidden" id="header-page-title">Project Description</div>
                        </div>
                        <div class="header-catalogue-container">
                            <painted-catalogue>
                                <div class="catalogue" id="catalogue">
                                    <template id="catalogue-item-template">
                                        <div class="catalogue-item">
                                            <a href=""></a>
                                        </div>
                                    </template>
                                    <template id="catalogue-divider-template">
                                        <div class="catalogue-item catalogue-divider"><span> | </span></div>
                                    </template>
                                    <!--  -->
                                    <div class="catalogue-item catalogue-arrow"><span> &gt; </span></div>

                                    <div class="catalogue-item">
                                        <a href="/home">home</a>
                                    </div>

                                    <div class="catalogue-item catalogue-divider"><span> | </span></div>

                                    <div class="catalogue-item">
                                        <a href="/project">project</a>
                                    </div>

                                    <div class="catalogue-item catalogue-divider"><span> | </span></div>

                                    <div class="catalogue-item catalogue-item-active">
                                        <a href="/project/description">project description</a>
                                    </div>

                                    <div class="catalogue-item catalogue-divider"><span> | </span></div>

                                    <div class="catalogue-item">
                                        <a href="/project/design">design</a>
                                    </div>

                                    <div class="catalogue-item catalogue-divider"><span> | </span></div>

                                    <div class="catalogue-item">
                                        <a href="/integrated-human-practice">integrated human practice</a>
                                    </div>

                                    <div class="catalogue-item catalogue-divider"><span> | </span></div>

                                    <div class="catalogue-item">
                                        <a href="/acknowledgements">acknowledgements</a>
                                    </div>

                                    <div class="catalogue-item catalogue-divider"><span> | </span></div>
                                </div>
                            </painted-catalogue>
                        </div>
                    </div>
                </header>
                <div class="header-spacer"></div>
            </painted-header>
            <painted-body>
                <div class="body-container">
                    <painted-title-card>
                        <div class="title-card-container">
                            <div class="background-box">
                                <div class="pattern"></div>
                            </div>
                            <div class="page-title use-parallax" id="title-name">Project Description</div>
                            <div class="page-title use-parallax" id="title-name-shadow">Project Description</div>
                            <div class="page-title use-parallax" id="title-name-box">Project Description</div>
                            <div id="sticker-container">
                                <img
                                    class="use-parallax"
                                    id="blue-pills"
                                    src="/assets/stickers/blue pills-Enhanced-SR.png"
                                />
                                <img
                                    class="use-parallax"
                                    id="colourful-pills"
                                    src="/assets/stickers/colourful pills-Enhanced-SR.png"
                                />
                                <img
                                    class="use-parallax"
                                    id="hold-pills"
                                    src="/assets/stickers/hold pills-Enhanced-SR.png"
                                />
                                <img
                                    class="use-parallax"
                                    id="orange-pills"
                                    src="/assets/stickers/orange pills-Enhanced-SR.png"
                                />
                                <img class="use-parallax" id="globe" src="/assets/stickers/globe-Enhanced-SR.png" />
                                <img class="use-parallax" id="gurney" src="/assets/stickers/gurney-Enhanced-SR.png" />
                            </div>
                        </div>
                    </painted-title-card>
                    <div class="main-container">
                        <painted-outline>
                            <nav>
                                <div id="outline-progress-pointer">‚û°Ô∏è</div>
                                <div class="outline">
                                    <ul id="outline-tree">
                                        <template id="outline-heading-template">
                                            <li>
                                                <a>heading</a>
                                                <ul></ul>
                                            </li>
                                        </template>

                                        <li>
                                            <a href="#inspiration" id="--outline-inspiration">Inspiration</a>
                                            <ul></ul>
                                        </li>

                                        <li>
                                            <a href="#background" id="--outline-background">Background</a>
                                            <ul>
                                                <li>
                                                    <a
                                                        href="#antibiotic-resistance"
                                                        id="--outline-antibiotic-resistance"
                                                        >Antibiotic Resistance</a
                                                    >
                                                    <ul></ul>
                                                </li>

                                                <li>
                                                    <a
                                                        href="#klebsiella-pneumoniae"
                                                        id="--outline-klebsiella-pneumoniae"
                                                        >Klebsiella pneumoniae</a
                                                    >
                                                    <ul></ul>
                                                </li>
                                            </ul>
                                        </li>

                                        <li>
                                            <a href="#our-solution" id="--outline-our-solution">Our Solution</a>
                                            <ul></ul>
                                        </li>

                                        <li>
                                            <a href="#our-vision" id="--outline-our-vision">Our Vision</a>
                                            <ul></ul>
                                        </li>

                                        <li>
                                            <a href="#references" id="--outline-references">References</a>
                                            <ul></ul>
                                        </li>
                                    </ul>
                                </div>
                            </nav>
                        </painted-outline>
                        <main>
                            <painted-content
                                ><p>üöß Under construction</p>
                                <div class="scroll-marker" data-scroll-marker-level="H1" id="inspiration"></div
                                ><section
                                    ><h1 id="inspiration">Inspiration</h1
                                    ><p
                                        >The COVID-19 pandemic has popularised the concept and the use of point-of-care
                                        testing kits. Inspired by this, our team is attempting to develop a novel
                                        point-of-care testing kit that is versatile to detect different types of
                                        antibiotic resistance. We initially discovered a potential tool that might help
                                        us in constructing our kit, which is the 8-17 deoxyribozymes (DNAzymes),
                                        together with the stem-loops and fluoroprobes-containing oligonucleotides. These
                                        DNAzymes are capable of receiving inputs at their stem-loops, which will then
                                        expose their catalytic sites, and cause cleavage of the oligonucleotides to
                                        produce fluorescence [1]. Using this biological logic gate system, we were
                                        planning to utilise the DNAzymes stem-loops to detect resistance genes. However,
                                        upon consulting the ideas with our Principal Investigators, we realised that a
                                        detection kit that depends on fluorescence-based results is not the ideal choice
                                        for constructing a point-of-care diagnostic kit. Thus, we shifted our focus to
                                        develop a kit that generates colorimetric results instead. </p
                                    ><div class="scroll-marker" data-scroll-marker-level="H1" id="background"></div
                                ></section>

                                <section
                                    ><h1 id="background">Background</h1
                                    ><div
                                        class="scroll-marker"
                                        data-scroll-marker-level="H2"
                                        id="antibiotic-resistance"
                                    ></div
                                    ><section
                                        ><h2 id="antibiotic-resistance">Antibiotic Resistance</h2
                                        ><p
                                            >Antibiotics, used for over a century to treat bacterial infections, are one
                                            of the most successful medical interventions. However, antibiotic resistance
                                            has increased due to overuse, causing previously manageable diseases to
                                            resurface. Many infectious diseases, which were wiped out by antibiotics,
                                            have become a more severe problem in recent years. </p
                                        ><p
                                            >In a study published in 2022, it was estimated that 4.95 millions (95% CI
                                            3.62-6.57 millions) of deaths were associated with bacterial antimicrobial
                                            resistance (AMR) in 2019, and 1.27 millions of it were caused by bacterial
                                            AMR [2]. These figures indicate that deaths due to AMR represent a major
                                            global health concern, comparable in scale to leading causes of mortality
                                            such as ischemic heart disease, stroke, and chronic obstructive pulmonary
                                            disease [3].</p
                                        ><p
                                            >Out of the 4.95 millions of bacterial AMR associated deaths, 4.3 millions
                                            are occurring in low-income and middle-income countries (LMICs) [4]. This
                                            indicates a necessary step up in LMICs‚Äô infection prevention and control, as
                                            well as access to affordable diagnosis. According to the Lancet Series on
                                            Antimicrobial Resistance, if interventions are implemented to align
                                            infection prevention and control standards in LMICs‚Äô healthcare settings
                                            with the standards in high-income countries, we will be able to prevent up
                                            to 337,000 AMR associated deaths annually [4].</p
                                        ><p
                                            >The rise of antibiotic resistant trends is mainly driven by the high
                                            selection pressure caused by the increasing use and misuse of antibiotics
                                            over the years. Over the past two decades, global antimicrobial use has
                                            increased by 46% [3]. The usage of antibiotics to cure infections has
                                            actually provided advantages for those bacteria that have resistance,
                                            causing the further spread of resistant bacteria since they survive better
                                            in the environment compared to the susceptible ones [3].</p
                                        ><p
                                            >In the natural process, horizontal gene transfer might also occur among
                                            species of bacteria. This process enables bacteria to exchange their genetic
                                            material, including antibiotic resistance genes (ARGs), across diverse
                                            species, which greatly facilitates collaboration among bacterial populations
                                            in the development of multidrug resistance (MDR) [5]. Moreover, MDR leads to
                                            the escalation in severity of the problem. The most evident instance is
                                            Superbugs, a strain of bacteria that are resistant to several types of
                                            antibiotics, which greatly challenges the treatment process of a bacterial
                                            infection. </p
                                        ><p
                                            >On a larger scope, the problem of AMR causes larger problems than just
                                            increased challenge in treating bacterial infection. It also complicates the
                                            treatment of chronic kidney disease, diabetes and associated urinary tract
                                            and foot infections, chronic obstructive pulmonary disease, liver cirrhosis,
                                            as well as surgical care due to the risk of exposure to resistant infections
                                            [3]. In addition, AMR impedes progress towards the global childhood survival
                                            rate targeted by the Sustainable Development Goal 3. This is because one
                                            third of newborn deaths are caused by infections, and half of these
                                            infection-related deaths are specifically attributed to sepsis [3].
                                            Concerningly, the pathogens driving these deadly infections are becoming
                                            increasingly resistant to the most widely used antibiotic treatments [3]. </p
                                        ><p
                                            >Furthermore, the rise of antimicrobial resistance has diminished the
                                            effectiveness of previously useful antimicrobial drugs, causing access to
                                            antimicrobials that were previously considered second-line treatments has
                                            become increasingly crucial [3]. The Organization for Economic Cooperation
                                            and Development (OECD) projects a twofold surge in resistance to last-resort
                                            antibiotics by 2035 compared to 2005 levels [6].</p
                                        ><p
                                            >In addressing the problems of antibiotic resistance, the Lancet series in
                                            2024 proposed three goals to be achieved globally by 2030; 10% decrease in
                                            deaths from AMR, 20% reduction in inappropriate human antibiotic use, and
                                            30% reduction in inappropriate animal antibiotic use [7]. These goals can
                                            only be achieved with optimised surveillance, including diagnosis to prevent
                                            the misuse of ineffective antibiotics which only further drive resistance.
                                            However, current technologies for diagnosing antibiotic resistance, such as
                                            minimum inhibitory concentration (MIC), require lengthy culturing, while
                                            genetic tests like PCR necessitate trained personnel. Additionally, routine
                                            bacteriological culture testing is available in only 1.3% of laboratories in
                                            sub-Saharan Africa [8]. To counteract the rising trend of antibiotic
                                            resistance, and to provide better access to diagnostic kits in low-resource
                                            settings, a cheaper, faster, and simpler technology is needed.</p
                                        ><div
                                            class="scroll-marker"
                                            data-scroll-marker-level="H2"
                                            id="klebsiella-pneumoniae"
                                        ></div></section
                                    ><section
                                        ><h2 id="klebsiella-pneumoniae"><em>Klebsiella pneumoniae</em></h2
                                        ><p
                                            ><em>Klebsiella pneumoniae</em> has often been linked to causing pneumonia,
                                            especially in people who have alcohol use disorder or diabetes mellitus [9].
                                            It is a gram-negative, encapsulated, and non-motile type of bacterium found
                                            in the environment, mainly colonising human mucosal surfaces of the
                                            oropharynx and gastrointestinal (GI) tract [9].
                                            <em>Klebsiella pneumoniae</em> infection is best treated with third- and
                                            fourth-generation cephalosporins, quinolones, or carbapenems [10]. However,
                                            over the years, <em>Klebsiella pneumoniae</em> has shown to produce
                                            extended-spectrum beta-lactamase (ESBL) that breaks down and inactivates
                                            beta-lactam antibiotics, including cephalosporin, rendering third-generation
                                            cephalosporin drugs ineffective for treating
                                            <em>Klebsiella pneumoniae</em> infections.</p
                                        ><p
                                            >Additionally, cases of carbapenem-resistant
                                            <em>Klebsiella pneumoniae</em> have also been discovered. This thus
                                            classifies Klebsiella pneumonia as one of the Carbapenemase-producing
                                            Enterobacteriaceae (CPE). Similar to beta-lactamase, carbapenem resistance
                                            is conferred by the production of the carbapenemase enzyme which is capable
                                            of hydrolyzing and disabling the drug molecule [11], [12]. More
                                            concerningly, carbapenemases are encoded on plasmids, for instance, as
                                            blaKPC and blaNDM-1 [13]. This means that it can be easily transferred
                                            between bacteria through horizontal gene transfer, resulting in a more
                                            vigorous spread of the resistance [14]. </p
                                        ><p
                                            >In the estimated 1.27 million deaths caused by AMR,
                                            <em>Klebsiella pneumoniae</em> was one of the six leading pathogens [2]. In
                                            sub-Saharan Africa, <em>Klebsiella pneumoniae</em> contributed to 19.9%
                                            deaths caused by AMR and 17.5% of AMR-associated mortality [2]. Other than
                                            that, <em>Klebsiella pneumoniae</em> is one of the most common causes of
                                            neonatal sepsis in low resource settings, such as in sub-Saharan Africa [3],
                                            [15]. Although it is estimated that only 3-5% of all community-acquired
                                            pneumonia in Western culture is related to
                                            <em>Klebsiella pneumoniae</em> infection, in developing countries such as
                                            African countries, for example, community-acquired
                                            <em>Klebsiella pneumoniae</em> accounts for roughly 15% of all pneumonia
                                            cases [9].</p
                                        ><p
                                            >In terms of its resistant variants, resistant
                                            <em>Klebsiella pneumoniae</em> commonly causes community-acquired urinary
                                            tract infections along with resistant Escherichia coli, Proteus mirabilis,
                                            and Staphylococcus saprophyticus [3]. According to the World Health
                                            Organization, <em>Klebsiella pneumoniae</em> showed elevated resistance
                                            levels against major antibiotics, compromising the effectiveness of these
                                            last-resort drugs and increasing the risk of untreatable infections [6].
                                            This indicates that <em>Klebsiella pneumoniae</em> is one of the most
                                            significant pathogens when it comes to antibiotic resistance. Additionally,
                                            the 2024 Lancet series emphasised on the needs for novel strategies to
                                            address the burden of ESKAPE pathogens, which includes
                                            <em>Klebsiella pneumoniae</em> [4], [13].</p
                                        ><p
                                            >With this regard, we consider <em>Klebsiella pneumoniae</em> as our
                                            starting focus in developing our diagnosis method. With its level of
                                            urgency, especially in low-resource settings, performing diagnosis of
                                            resistant <em>Klebsiella pneumoniae</em> in a simple and low-cost manner
                                            will benefit the community for a more effective usage of antibiotics as well
                                            as for enhanced surveillance.</p
                                        ><div
                                            class="scroll-marker"
                                            data-scroll-marker-level="H1"
                                            id="our-solution"
                                        ></div></section
                                ></section>

                                <section
                                    ><h1 id="our-solution">Our Solution</h1
                                    ><p
                                        >We are developing a point-of-care test kit, ResiSense, for more efficient
                                        diagnosis, using cell-free systems. This proposed testing system consists of
                                        three parts: target gene extraction, rolling circle amplification (RCA), and
                                        signal expression.</p
                                    ><p
                                        >After cell lysis releases bacterial DNA, a snippet of the target gene, which is
                                        responsible for antibiotic resistance, is cut using a pair of restriction
                                        enzymes and nickase. The phi-29 polymerase aids in releasing the target gene as
                                        ss-DNA. This target gene serves as a primer and triggers the formation of
                                        peroxidase-mimicking DNAzymes through rolling circle amplification (RCA).
                                        Finally, the G-quadruplex DNAzymes cause a colour change in the solution,
                                        indicating the presence of antibiotic-resistant genes in bacteria.</p
                                    ><p
                                        >All processes in our detection system are designed to occur in isothermal
                                        conditions, specifically in room temperature. Our aim is to create a versatile,
                                        easily programmable system that can detect various antibiotic resistance genes,
                                        starting with those related to <em>Klebsiella pneumoniae</em>.</p
                                    ><div class="scroll-marker" data-scroll-marker-level="H1" id="our-vision"></div
                                ></section>

                                <section
                                    ><h1 id="our-vision">Our Vision</h1
                                    ><p
                                        >As reported in the 2024 Lancet Series on Antimicrobial Resistance, preserving
                                        the effectiveness of antibiotics will depend on accurate and timely diagnosis of
                                        bacterial infections [7]. However, the scaling up of diagnostic technologies
                                        faces a number of challenges, including technological, economic, and behavioural
                                        challenges [7]. Thus, this project is mainly about developing an affordable,
                                        simple, yet accurate diagnostic kit, aimed to provide better accessibility to
                                        diagnostic technologies in low-resource settings by eliminating the problems of
                                        lengthy culturing, the need for specialised machines, and trained personnel.</p
                                    ><p
                                        >After successfully running our systems to detect the resistance genes of
                                        <em>Klebsiella pneumoniae</em>, we are planning to expand the project to detect
                                        resistance genes of other bacterial species, as well as the species itself. We
                                        understand that diagnosing resistance is insufficient without the information of
                                        species. Thus, in the future, we will adapt the detection system to also
                                        recognize and report the bacteria species that cause the infection. </p
                                    ><p
                                        >In the long run, with the lower cost and decent turnaround time, our technology
                                        has the potential to help doctors choose the right antibiotics to prescribe,
                                        saving lives that would not be possible to save without access to MALDI-TOF. Our
                                        technology also helps prevent the spread of antibiotic resistance by alerting
                                        the medical professionals of its existence. Financially, we target to open up a
                                        new market that was previously unreachable with the current technologies.
                                        Lastly, we aim to create an impact in research by developing a methodology that
                                        could be readily adapted to detecting other segments of genes in any organism,
                                        helping other researchers develop accessible diagnostic tests based on our
                                        platform.</p
                                    ><div class="scroll-marker" data-scroll-marker-level="H1" id="references"></div
                                ></section>

                                <section
                                    ><h1 id="references">References</h1
                                    ><ol>
                                        <li
                                            >M. N. Stojanoviƒá and D. Stefanoviƒá, ‚ÄúDeoxyribozyme-based half-adder,‚Äù
                                            Journal of the American Chemical Society, vol. 125, no. 22, pp. 6673‚Äì6676,
                                            May 2003.
                                            <a
                                                href="https://www.doi.org/10.1021/ja0296632"
                                                target="_blank"
                                                rel="noopener noreferrer"
                                                >‚§¥Ô∏è</a
                                            ></li
                                        >
                                        <li
                                            >C. J. Murray et al., ‚ÄúGlobal burden of bacterial antimicrobial resistance
                                            in 2019: A systematic analysis,‚Äù The Lancet, vol. 399, no. 10325, pp.
                                            629‚Äì655, Feb. 2022.
                                            <a
                                                href="https://www.doi.org/10.1016/s0140-6736(21)02724-0"
                                                target="_blank"
                                                rel="noopener noreferrer"
                                                >‚§¥Ô∏è</a
                                            ></li
                                        >
                                        <li
                                            >I. N. Okeke et al., ‚ÄúThe scope of the Antimicrobial Resistance Challenge,‚Äù
                                            The Lancet, vol. 403, no. 10442, pp. 2426‚Äì2438, Jun. 2024.
                                            <a
                                                href="https://www.doi.org/10.1016/s0140-6736(24)00876-6"
                                                target="_blank"
                                                rel="noopener noreferrer"
                                                >‚§¥Ô∏è</a
                                            ></li
                                        >
                                        <li
                                            >J. A. Lewnard et al., ‚ÄúBurden of bacterial antimicrobial resistance in
                                            low-income and middle-income countries avertible by existing interventions:
                                            An evidence review and modelling analysis,‚Äù The Lancet, vol. 403, no. 10442,
                                            pp. 2439‚Äì2454, Jun. 2024.
                                            <a
                                                href="https://www.doi.org/10.1016/s0140-6736(24)00862-6"
                                                target="_blank"
                                                rel="noopener noreferrer"
                                                >‚§¥Ô∏è</a
                                            ></li
                                        >
                                        <li
                                            >D. Sun, K. Jeannot, Y. Xiao, and C. W. Knapp, ‚ÄúEditorial: Horizontal gene
                                            transfer mediated bacterial antibiotic resistance,‚Äù Frontiers in
                                            Microbiology, vol. 10, Aug. 2019.
                                            <a
                                                href="https://www.doi.org/10.3389/fmicb.2019.01933"
                                                target="_blank"
                                                rel="noopener noreferrer"
                                                >‚§¥Ô∏è</a
                                            ></li
                                        >
                                        <li
                                            >‚ÄúAntimicrobial resistance,‚Äù World Health Organization,
                                            <a
                                                href="https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance"
                                                target="_blank"
                                                rel="noopener noreferrer"
                                                >‚§¥Ô∏è</a
                                            >
                                            (accessed Apr. 14, 2024).</li
                                        >
                                        <li
                                            >‚ÄúSustainable Access to Effective Antibiotics: An Executive Summary for The
                                            Lancet‚Äôs Series,‚Äù The Lancet Series on Antimicrobial Resistance: The need
                                            for sustainable access to effective antibiotics,
                                            <a
                                                href="https://www.thelancet.com/series/antibiotic-resistance?dgcid=tlcom_infographic_amr2024_lancet"
                                                target="_blank"
                                                rel="noopener noreferrer"
                                                >‚§¥Ô∏è</a
                                            >
                                            (accessed Jun. 17, 2024).
                                        </li>
                                        <li
                                            >R. Laxminarayan et al., ‚ÄúExpanding antibiotic, vaccine, and diagnostics
                                            development and access to tackle antimicrobial resistance,‚Äù The Lancet, vol.
                                            403, no. 10443, pp. 2534‚Äì2550, Jun. 2024.
                                            <a
                                                href="https://www.doi.org/10.1016/s0140-6736(24)00878-x"
                                                target="_blank"
                                                rel="noopener noreferrer"
                                                >‚§¥Ô∏è</a
                                            ></li
                                        >
                                        <li
                                            >J. V. Ashurst and A. Dawson, "Klebsiella Pneumonia," StatPearls [Internet].
                                            Treasure Island (FL): StatPearls Publishing, Jan. 2024. [Online]. Available:
                                            <a
                                                href="https://www.ncbi.nlm.nih.gov/books/NBK519004/"
                                                target="_blank"
                                                rel="noopener noreferrer"
                                                >‚§¥Ô∏è</a
                                            >. (accessed Jun. 18, 2024).</li
                                        >
                                        <li
                                            >S. E. Prince, K. A. Dominger, B. A. Cunha, and N. C. Klein, ‚ÄúKlebsiella
                                            pneumoniae pneumonia,‚Äù Heart &amp; Lung, vol. 26, no. 5, pp. 413‚Äì417,
                                            Sep./Oct. 1997.
                                            <a
                                                href="https://www.doi.org/10.1016/s0147-9563(97)90028-5"
                                                target="_blank"
                                                rel="noopener noreferrer"
                                                >‚§¥Ô∏è</a
                                            ></li
                                        >
                                        <li
                                            >L. D. Hughes, A. Aljawadi, and A. Pillai, ‚ÄúAn overview of carbapenemase
                                            producing Enterobacteriaceae (CPE) in Trauma and Orthopaedics,‚Äù Journal of
                                            Orthopaedics, vol. 16, no. 6, pp. 455‚Äì458, Nov./Dec. 2019.
                                            <a
                                                href="https://www.doi.org/10.1016/j.jor.2019.06.026"
                                                target="_blank"
                                                rel="noopener noreferrer"
                                                >‚§¥Ô∏è</a
                                            ></li
                                        >
                                        <li
                                            >T. R. Walsh, ‚ÄúEmerging Carbapenemases: A global perspective,‚Äù International
                                            Journal of Antimicrobial Agents, vol. 36, pp. S8‚ÄìS14, Nov. 2010.
                                            <a
                                                href="https://www.doi.org/10.1016/s0924-8579(10)70004-2"
                                                target="_blank"
                                                rel="noopener noreferrer"
                                                >‚§¥Ô∏è</a
                                            ></li
                                        >
                                        <li
                                            >S. Santajit and N. Indrawattana, ‚ÄúMechanisms of Antimicrobial Resistance in
                                            ESKAPE Pathogens,‚Äù BioMed Research International, vol. 2016, Jan. 2016.
                                            <a
                                                href="https://www.doi.org/10.1155/2016/2475067"
                                                target="_blank"
                                                rel="noopener noreferrer"
                                                >‚§¥Ô∏è</a
                                            ></li
                                        >
                                        <li
                                            >‚ÄúCarbapenemase-producing Enterobacteriaceae (CPE),‚Äù National Institute for
                                            Communicable Diseases,
                                            <a
                                                href="https://www.nicd.ac.za/diseases-a-z-index/carbapenemase-producing-enterobacteriaceae-cpe"
                                                target="_blank"
                                                rel="noopener noreferrer"
                                                >‚§¥Ô∏è</a
                                            >
                                            (accessed Jun. 19, 2024).</li
                                        >
                                        <li
                                            >U. Okomo et al., ‚ÄúAetiology of invasive bacterial infection and
                                            antimicrobial resistance in neonates in sub-Saharan africa: A systematic
                                            review and meta-analysis in line with the Strobe-ni reporting guidelines,‚Äù
                                            The Lancet Infectious Diseases, vol. 19, no. 11, pp. 1219‚Äì1234, Nov. 2019.
                                            <a
                                                href="https://www.doi.org/10.1016/s1473-3099(19)30414-1"
                                                target="_blank"
                                                rel="noopener noreferrer"
                                                >‚§¥Ô∏è</a
                                            ></li
                                        >
                                    </ol></section
                                >
                            </painted-content></main
                        >
                        <painted-sidebar>
                            <aside>
                                <a href="#"> üîù </a>
                            </aside>
                        </painted-sidebar>
                    </div>
                </div>
            </painted-body>
            <painted-footer>
                <footer>
                    <div class="footer-banner">
                        <div class="resisense">
                            <div class="resisense-logo">
                                <img src="/assets/logos/resisense/ResiSense Green Logo.svg" alt="ResiSense logo" />
                            </div>
                            <div class="resisense-logo-aside">
                                <div class="resisense-name"> ResiSense </div>
                                <div class="socials">
                                    <div class="social">
                                        <a
                                            href="https://www.instagram.com/cuhkigem2024/"
                                            target="_blank"
                                            rel="noopener noreferrer"
                                        >
                                            <img src="/assets/icons/instagram icon.svg" alt="Instagram icon" />
                                            <span> cuhkigem2024 </span>
                                        </a>
                                    </div>
                                    <div class="social">
                                        <a
                                            href="mailto:cuhkigem2024@gmail.com"
                                            target="_blank"
                                            rel="noopener noreferrer"
                                        >
                                            <img src="/assets/icons/email icon.svg" alt="Email icon" />
                                            <span> cuhkigem2024@gmail.com </span>
                                        </a>
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="divider"></div>
                        <div class="logo-container-wrapper">
                            <div> Affiliated with: </div>
                            <div class="cuhk-department-logo-container">
                                <a href="https://www.cuhk.edu.hk" target="_blank" rel="noopener noreferrer">
                                    <img src="/assets/logos/cuhk logo horizontal.svg" alt="CUHK logo" />
                                </a>
                                <a href="https://www.bme.cuhk.edu.hk" target="_blank" rel="noopener noreferrer">
                                    <img src="/assets/logos/bme logo.svg" alt="CUHK BME logo" />
                                </a>
                                <a href="https://www.sls.cuhk.edu.hk" target="_blank" rel="noopener noreferrer">
                                    <img src="/assets/logos/sls logo.svg" alt="CUHK SLS logo" />
                                </a>
                            </div>
                            <div> Sponsored by: </div>
                            <div class="sponsor-logo-container">
                                <a href="https://opentrons.com" target="_blank" rel="noopener noreferrer">
                                    <img src="/assets/logos/opentrons logo.svg" alt="Opentrons logo" />
                                </a>
                                <a href="https://www.idtdna.com" target="_blank" rel="noopener noreferrer">
                                    <img src="/assets/logos/idt logo.svg" alt="IDT logo" />
                                </a>
                                <a href="https://www.neb.com" target="_blank" rel="noopener noreferrer">
                                    <img src="/assets/logos/neb logo.svg" alt="NEB logo" />
                                </a>
                                <a href="https://www.hklss.org" target="_blank" rel="noopener noreferrer">
                                    <img src="/assets/logos/hklss logo repacked.svg" alt="HKLSS logo" />
                                </a>
                                <a href="https://abehk.fed.cuhk.edu.hk" target="_blank" rel="noopener noreferrer">
                                    <img src="/assets/logos/hkabe logo.svg" alt="HKABE logo" />
                                </a>
                            </div>
                        </div>
                    </div>
                    <div class="footer-spacer"></div>
                    <div class="footer-persistent">
                        <div class="repository-container">
                            <!-- Repository links -->
                            <span>
                                Repository:
                                <a href="https://github.com/ResiSense/ResiSense.github.io" target="_blank">
                                    <img src="/assets/icons/github icon.svg" alt="GitHub icon" />
                                </a>
                                <a href="https://gitlab.igem.org/2024/hongkong-cuhk" target="_blank">
                                    <img src="/assets/icons/gitlab icon.svg" alt="GitLab icon" />
                                </a>
                            </span>
                        </div>
                        <div class="license-container">
                            <!-- Licensing https://creativecommons.org/licenses/by/4.0/ -->
                            <span>
                                ¬©Ô∏è 2024 ResiSense. Licensed under
                                <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">
                                    <img
                                        src="/assets/icons/creative common/Creative Common CC icon.svg"
                                        alt="Creative Commons icon"
                                    />
                                    <img
                                        src="/assets/icons/creative common/Creative Common BY icon.svg"
                                        alt="Creative Commons BY icon"
                                    />
                                    CC BY 4.0</a
                                >. All rights reserved.
                            </span>
                        </div>
                    </div>
                </footer>
            </painted-footer>
        </painted-template>
    </body></html
>
